In his retraction note last week, the journal’s editor-in-chief Martin van den Berg cited a litany of serious flaws. Read more at straitstimes.com.
The scientific journal Regulatory Toxicology and Pharmacology retracted a 2000 study that concluded “under present and expected conditions of new use, there is no potential for Roundup herbicide to pose a health risk to humans.”
The paper, which had a major impact on policymaking, appears to have been based on unpublished studies by the controversial agricultural company.
Paper published in 2000 found glyphosate was not harmful, while internal emails later revealed company’s influence
The Trump administration, meanwhile, aims to shield its manufacturer from lawsuits.
:max_bytes(150000):strip_icc()/2833920Fall20sprayer-2000-31b77901f86b4fae87c6065653002776.jpg)
A paper widely cited as demonstrating the safety of glyphosate has been retracted, according to the co-editor of the journal in which it was published. The 25-year-old article “has been widely regarded as a hallmark paper in the discourse surrounding the carcinogenicity of glyphosate and Roundup,” the widely used herbicide that has glyphosate as its active ingredient, said Co-Editor Martin van den Berg.
An influential research article that claimed a popular weed-killer was safe has been retracted 25 years after it was published, prompting environment groups in Canada to ask the federal government to review the science on glyphosate use.
OTTAWA — An influential research article that claimed a popular weed-killer was safe has been retracted 25 years after it was published, prompting environment groups in Canada to ask the federal government to review the science on glyphosate use.
A case by the San Francisco attorney documents Big Food's use of ultraprocessed food to create addicts in a repeat of the tobacco playbook.
The Trump administration asks the U.S. Supreme Court to hear Bayer's case seeking to stop thousands of Roundup cancer lawsuits against the company.
The drop in air travel during the pandemic kept Wittke at home more and affected his mental health, Vargas told Reuters. Trump administration backs Bayer's bid to curb Roundup lawsuits President Donald Trump's administration urged the U.S. Supreme Court on Monday to take up Bayer’s bid to curtail thousands of lawsuits claiming its Roundup weedkiller causes cancer, pushing the group's shares to their highest in almost two years.
:max_bytes(150000):strip_icc()/48825574002_9227c49096_o2028129-1-2000-ca7cee9e91824f96b9ed11b914a30748.jpg)
The Trump administration is backing Bayer’s bid for Supreme Court review of whether the Federal Insecticide, Fungicide, and Rodenticide Act pre-empts pesticide lawsuits filed in state courts.
Bayer saddled itself with the Monsanto/Roundup garbage barge over fierce investor protest, and is now seeking Supremes relief.
John Sauer bolstered Bayer’s effort to limit the lawsuits and potentially avert billions of dollars in damages, saying the company was correct that the federal law governing pesticides preempts lawsuits that make claims over the products under state law. Bankrupt Genesis Health picks insider bid for its nursing homes Genesis HealthCare said on Monday that an insider bid had won a bankruptcy auction for all of its assets, which would allow the same ownership group to maintain control of the company's nursing homes while using bankruptcy to slash debts and medical malpractice claims.
Bayer jumped over 12% to a near two-year high after the Trump administration urged the U.S. Supreme Court on Monday to take up the company's bid to curtail thousands of lawsuits claiming its Roundup weedkiller caused cancer. The stock helped keep the broader healthcare index afloat, up 0.2%, offsetting losses from Wegovy maker Novo Nordisk, which fell 2.3%.
The National Farmers Union (NFU) plans to lobby the federal government for farmers to be guaranteed an annual basic income of $50,000.
Dublin-based Iseq index underperformed on the day, falling 0.77% as Ryanair and Kerry take a hit
Elsewhere, UK lenders passed the latest Bank of England stress tests.
:max_bytes(150000):strip_icc()/GettyImages-2206406924-0beb558aaa104bb1b9f43da1afcabb11.jpg)
Shares of Bayer are surging on their home exchange in Germany after the U.S. Solicitor General supported its efforts to have the Supreme Court review rulings on whether Roundup weed killer, produced by Bayer-owned Monsanto, needs a cancer risk warning label.
If you believe you have a legal claim, fill out the form below. This is for demonstration purposes only.
PROVIDING YOUR INFORMATION DOES NOT ESTABLISH AN ATTORNEY-CLIENT RELATIONSHIP AND YOUR INFORMATION MAY BE SHARED WITH A DIFFERENT LAW FIRM WHO MAY CONTACT YOU.